Company web. site http://www.moleculin.com
Shares Outstanding, 21,470 Million
Moleculin Biotech, Inc. (Nasdaq: MBRX) to Ring The Nasdaq Stock Market Closing Bell in celebration of IPO
Metabasis Therapeutics (NASDAQ:MBRX)
Historical Stock Chart
Moleculin Biotech (Nasdaq:MBRX), a preclinical and clinical-stage pharmaceutical company focused on the development of anti-cancer drug candidates, will visit the Nasdaq MarketSite in Times Square to celebrate its initial public offering (IPO).
In honor of the occasion, Walter Klemp, Chief Executive Officer, will ring the Closing Bell.
Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio
Thursday, June 2, 2016 – 3:45 p.m. to 4:00 p.m. ET
Moleculin Biotech Media Contact: